Joo Dong Park

6PUBLICATIONS
20CO-AUTHORS
Predictive and prognostic markersRadiation therapyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 12, 2025
Photosensitizing Lipid Nanoparticles for Ferroptosis-Enhanced Photodynamic Cancer Therapy via GPX4 Silencing.

Ga-Hyun Bae, Seungyong Shin, Joo Dong Park

|Mar 03, 2025
Dual-Functional Hafnium Oxide Nanoplatform Combining High-Z Radiosensitization With Bcl-2 Gene Silencing for Enhanced Cancer Radiotherapy.

Seungyong Shin, Ga-Hyun Bae, Jun-Hyeok Han

|Jan 08, 2025
Advancing Natural Killer Cell Therapy: Genetic Engineering Strategies for Enhanced Cancer Immunotherapy.

Joo Dong Park, Ha Eun Shin, Yeon Su An

|Jul 08, 2023
The ELK3-DRP1 axis determines the chemosensitivity of triple-negative breast cancer cells to CDDP by regulating mitochondrial dynamics.

Joo Dong Park, Hye Jung Jang, Seung Hee Choi

|Aug 26, 2022
Chemical priming of natural killer cells with branched polyethylenimine for cancer immunotherapy.

Seung Hee Choi, Hye Jin Kim, Joo Dong Park

|Jul 20, 2022
ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics.

Joo Dong Park, Kwang-Soo Kim, Seung Hee Choi

Pageof 1

Frequent Collaborators

3 joint publications

Seung Hee Choi

3 joint publications

Wooram Park

2 joint publications

Seung Hee Choi

2 joint publications

Ha Eun Shin